Get the Stockscreener App
20.06
8.82%
-1.94
After Hours:
20.30
0.24
+1.20%
Alamar Biosciences Inc stock is traded at $20.06, with a volume of 260.18K.
It is down -8.82% in the last 24 hours and down -17.35% over the past month.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
See More
Previous Close:
$22.00
Open:
$21.95
24h Volume:
260.18K
Relative Volume:
2.26
Market Cap:
$1.39B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.87%
1M Performance:
-17.35%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$19.87
$22.50
1-Week Range:
$19.87
$22.50
52-Week Range:
$19.87
$27.20
Alamar Biosciences Inc Stock (ALMR) Company Profile
Name
Alamar Biosciences Inc
Sector
Industry
Phone
510-626-9888
Address
47071 BAYSIDE PARKWAY, FREMONT
Compare ALMR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
20.06 | 1.52B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc Stock (ALMR) Latest News
Number of shareholders of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences, Inc. (ALMR) Net Income (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Liabilities - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash Equivalents (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Enterprise Value - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Equity (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Assets (TTM) - Zacks Investment Research
This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35 - Moomoo
Stifel Initiates Alamar Biosciences at Buy With $28 Price Target - marketscreener.com
Leerink Initiates Alamar Biosciences at Outperform With $35 Price Target - marketscreener.com
Alamar Biosciences, Inc. (ALMR) Market Cap - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (TTM) - Zacks Investment Research
Stifel initiates Alamar Biosciences stock with buy rating - Investing.com UK
JPMorgan initiates Alamar Biosciences stock with overweight rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Alamar Biosciences stock with overweight rating - Investing.com India
Stifel initiates Alamar Biosciences stock with buy rating By Investing.com - Investing.com India
Alamar Biosciences, Inc. (ALMR) Gross Margin (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Assets (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Long Term Debt (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Dividend Yield (TTM) - Zacks Investment Research
Alamar Biosciences Revenue Jump And IPO Spotlight Neuro Focus Potential - Sahm
Alamar Biosciences, Inc. (ALMR) Ps Ratio (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Net Income (TTM) - Zacks Investment Research
ALMR: Alamar Biosciences, Inc.Price & Consenus Chart - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Profit Margin (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Price To Cash Flow - Zacks Investment Research
Alamar Biosciences Q1 Loss Widens, Revenue Rises - Moomoo
Alamar Biosciences 1Q Rev $26M >ALMR - Moomoo
Alamar Biosciences, Inc. 1Q 2026: Revenue $26.04M, EPS $(1.74) — 10-Q Summary - TradingView
ALMR SEC FilingsAlamar Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Alamar Biosciences Reports First Quarter 2026 Financial Results - The Manila Times
Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share - marketscreener.com
Alamar Biosciences (Nasdaq: ALMR) posts 99% Q1 2026 revenue growth - Stock Titan
Earnings Flash (ALMR) Alamar Biosciences, Inc. Reports Q1 Revenue $26.0M - marketscreener.com
Fresh off a $220M IPO, Alamar expands neuro tests and posts $26M quarter - Stock Titan
Alamar Biosciences (ALMR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
ALMR Technical Analysis & Stock Price Forecast - Intellectia AI
Proteomics firm Alamar climbs 40% after upsized IPO - MSN
Investors can watch Alamar's BofA Healthcare Conference webcast May 12 - Stock Titan
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference - GlobeNewswire
Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference on May 12 - Pluang
Alamar Biosciences Inc - Reuters
Alamar Biosciences Index Debut And Shelf Filing Reshape Investor Tradeoffs - Sahm
Alamar Biosciences Inc Stock (ALMR) Financials Data
There is no financial data for Alamar Biosciences Inc (ALMR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):